MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS

Authors

  • Pirmatova Z.M.,Abdurakhmanova N.M. Tashkent State Medical University

Keywords:

rheumatoid arthritis, targeted therapy, JAK inhibitors, biologic DMARDs, early diagnosis, joint imaging, personalized medicine

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disorder that primarily affects synovial joints, leading to progressive cartilage and bone destruction. Advances in imaging techniques, such as musculoskeletal ultrasound and MRI, have improved early detection of joint inflammation and structural damage. Recent studies emphasize personalized medicine approaches, including genetic profiling and biomarker analysis, to tailor therapy for individual patients. Targeted therapies, such as JAK inhibitors and biologic DMARDs, have transformed disease management by reducing disease activity and preventing irreversible joint damage. Lifestyle interventions, including physical activity and dietary optimization, are increasingly recognized as adjunctive strategies to improve functional outcomes and quality of life. Current research also explores the long-term safety and cost-effectiveness of emerging biologic agents, as well as their impact on comorbidities commonly associated with RA, such as cardiovascular disease and osteoporosis.

References

Gudu T., Oztas M., Nikiphorou E. Contemporary approaches to the management of rheumatoid arthritis: precision and progress. Best Practice & Research Clinical Rheumatology. 2025.

Prasad P., Verma S., et al. Rheumatoid arthritis: advances in treatment strategies. Molecular Biology Reports. 2023.

Akram M., Daniyal M., et al. Traditional and modern management strategies for rheumatoid arthritis. Clinica Chimica Acta. 2021.

Brown P., Pratt A.G., Hyrich K.L. Therapeutic advances in rheumatoid arthritis. BMJ. 2024.

Ashiq K., Ashiq S., et al. An Updated Review on Rheumatoid Arthritis: Epidemiology, Pathophysiology, Diagnosis, and Current Approaches for Its Treatment. 2023.

Nascimento M.P., Azuelos A., et al. State of the Art in Novel Treatment Strategies in Rheumatoid Arthritis. Mediterranean Journal of Rheumatology. 2025.

Amjad M.A., Hamid Z. Modern Pharmacologic Management of Rheumatoid Arthritis: From Methotrexate to Targeted Therapies. 2025.

molen J.S., Aletaha D., McInnes I.B. Rheumatoid arthritis. The Lancet. 2020.

Brown P., Pratt A.G., Isaacs J.D. Mechanisms of action of methotrexate in rheumatoid arthritis. Clinical & Experimental Immunology. 2021.

McInnes I.B., Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Nature. 2020.

Sparks J.A. Rheumatoid arthritis. Annals of Internal Medicine. 2021.

van der Heijde D., et al. 2023 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological DMARDs. Annals of the Rheumatic Diseases. 2023.

Downloads

Published

2026-04-16

How to Cite

Pirmatova Z.M.,Abdurakhmanova N.M. (2026). MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS. Ethiopian International Journal of Multidisciplinary Research, 13(4), 1220–1223. Retrieved from https://www.eijmr.org/index.php/eijmr/article/view/6153